Shares of WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY – Get Free Report) reached a new 52-week high on Wednesday. The company traded as high as $27.80 and last traded at $27.80, with a volume of 220 shares trading hands. The stock had previously closed at $26.48.
Analyst Upgrades and Downgrades
Separately, Zacks Research raised WuXi AppTec from a “hold” rating to a “strong-buy” rating in a report on Friday, August 7th. One analyst has rated the stock with a Strong Buy rating and one has issued a Buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Strong Buy”.
Get Our Latest Research Report on WUXAY
WuXi AppTec Stock Performance
About WuXi AppTec
WuXi AppTec is a contract research, development and manufacturing organization (CRDMO) that provides services to pharmaceutical, biotechnology and medical-device companies. Its offerings span the drug-development process, including early-stage discovery, medicinal and synthetic chemistry, biology research, analytical testing, preclinical studies, clinical research support, process development and commercial manufacturing.
The company supports a broad range of therapeutic programs, with capabilities covering small-molecule drugs, biologics, chemical and pharmaceutical products, and cell and gene therapies.
Featured Articles
- Five stocks we like better than WuXi AppTec
- Inhibrx’s Insider Buying Adds Fuel to a High-Short-Interest Biotech Setup
- Alamos Gold’s 1 Million-Ounce Growth Story Is Hiding in Plain Sight
- Everyone in AI Is Quietly Copying Palantir’s Playbook
- Advanced Micro Devices Is Spending $8.2 Billion to Learn What AI Needs Next
Receive News & Ratings for WuXi AppTec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi AppTec and related companies with MarketBeat.com's FREE daily email newsletter.
